| Financial Year |
March 31 2023 |
| Monetary Funds |
147,578,019.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,293,954.00 |
| Accounts Receivable |
246,372,825.40 |
| Advances to Suppliers |
11,253,320.73 |
| Other Receivables |
4,309,513.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
91,228,616.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
470,998.71 |
| Total Current Assets |
544,118,963.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,554,116.30 |
| Long-term Equity Investment |
101,595,053.93 |
| Investment Properties |
39,800,330.08 |
| Fixed Assetes |
112,625,682.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,583,412.19 |
| R&D expenses |
-- |
| Goodwill |
254,096,045.37 |
| Long-Term Deferred and Prepaid Expenses |
9,207,130.34 |
| Deferred Income Tax Assets |
3,934,809.92 |
| Other Non-Current Assets |
1,765,300.00 |
| Sub-Total of Non-Current Assets |
593,866,115.07 |
| Total Assets |
1,137,985,078.15 |
| Short-Term Loans |
7,300,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,365,624.75 |
| Accounts Payable |
72,051,076.12 |
| Accounts Received In Advance |
10,276,510.07 |
| Employee Compensation Payable |
6,522,526.99 |
| Taxes Payable |
7,839,592.35 |
| Interest Payable |
-- |
| Dividend Payable |
598,991.05 |
| Other payables |
31,257,282.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,584,684.44 |
| Other Current Liabilities |
2,951,787.49 |
| Sub-Total of Current Liabilities |
176,543,608.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
994,617.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,584,333.30 |
| Total Liabilities |
180,127,941.32 |
| Paid-In Capital(Or Share Stock) |
524,198,348.00 |
| Capital Surplus |
784,881,409.25 |
| Surplus Reserve |
33,994,377.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-393,056,357.32 |
| Minority Stockholder's Interest |
8,939,358.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
948,917,777.86 |
| Owner's Equity（Stockholder's Equity） |
957,857,136.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,137,985,078.15 |
